COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 495: Articles 4941-4950  | Next

COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark
Shen, Q., Joyce, E. E., Ebrahimi, O. V., Didriksen, M., Lovik, A., Savarsdottir, K. S., Magnusdottir, I., Mikkelsen, D. H., Unnarsdottir, A. B., Hauksdottir, A., Hoffart, A., Kahler, A., Thordardottir, E. B., Eythorsson, E., Frans, E. M., Tomasson, G., Ask, H., Hardardottir, H., Jakobsdottir, J., Lehto, K., Lu, L., Andreassen, O., Sullivan, P., Palsson, R., Erikstrup, C., Ostrowski, S. R., Werge, T., Aspelund, T., Pedersen, O. B. V., Johnson, S. U., Fang, F., Valdimarsdottir, U.
10.1101/2023.04.18.23288720 — Posted: 2023-04-20
Sialoglycan binding triggers spike opening in a human coronavirus
Pronker, M. F., Creutznacher, R., Drulyte, I., Hulswit, R. J. G., Li, Z., van Kuppeveld, F. J. M., Snijder, J., Lang, Y., Bosch, B.-J., Boons, G.-J., Frank, M., de Groot, R. J., Hurdiss, D. L.
10.1101/2023.04.20.536837 — Posted: 2023-04-20
Mobilisation and analyses of publicly available SARS-CoV-2 data for pandemic responses
Rahman, N., O'Cathail, C., Zyoud, A., Sokolov, A., Oude Munnink, B., Grüning, B. A., Cummins, C., Amid, C., Nieuwenhuijse, D. F., Visontai, D., Yuan, D. Y., Gupta, D., Prasad, D., Gulyas, G. M., Rinck, G., McKinnon, J., Knaggs, J., Skiby, J. E., Steger, J., Szarvas, J., Gueye, K., Papp, K., Hoek, M., Kumar, M., Ventouratou, M. A., Bouquieaux, M.-C., Koliba, M., Mansurova, M., Haseeb, M., Worp, N., Harrison, P. W., Leinonen, R., Thorne, R., Selvakumar, S., Hunt, S., Venkataraman, S., Jayathilaka, S., Cezard, T., Maier, W., Waheed, Z., Iqbal, Z., Aarestrup, F. M., Csabai, I., Koopmans, M., Burdett, T., Cochrane, G.
10.1101/2023.04.19.537514 — Posted: 2023-04-20
Machine learning detection of SARS-CoV-2 high-risk variants
Li, L., Li, C., Li, N., Zou, D., Zhao, W., Xue, Y., Zhang, Z., Bao, Y., Song, S.
10.1101/2023.04.19.537460 — Posted: 2023-04-20
SARS-CoV-2 utilization of ACE2 from different bat species allows for virus entry and replication in vitro
Briggs, K., Sweeney, R., Blehert, D. S., Spackman, E., Suarez, D. L., Kapczynski, D. R.
10.1101/2023.04.19.537521 — Posted: 2023-04-20
Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations
Park, H.-S., Barranta, C., Yin, A., Lee, J., Caputo, C. A., Li, M., Yoon, S., Sitaris, I., Jedlicka, A., Eby, Y., Ram, M., Fernandez, R. E., Baker, O. R., Shenoy, A. G., Mosnaim, G. S., Fukuta, Y., Patel, B., Heath, S. L., Levine, A. C., Meisenberg, B. R., Spivak, E. S., Anjan, S., Huaman, M. A., Blair, J. E., Currier, J. S., Paxton, J. H., Gerber, J., Petrini, J., Broderick, P., Rausch, W., Cordisco, M., Hammel, J., Greenblatt, B., Cluzet, V. C., Cruser, D., Oei, K., Abinante, M., Hammitt, L. L., Sutcliffe, C. G., Forthal, D. N., Zand, M. S., Cachay, E. R., Raval, J. S., Kassaye, S. G., Marsh
10.1101/2023.04.13.23288353 — Posted: 2023-04-19
Post COVID-19 Condition, Work Ability and Occupational Changes: Results from a Population-based Cohort
Kerksieck, P., Ballouz, T., Haile, S. R., Schumacher, C., Lacy, J., Domenghino, A., Fehr, J. S., Bauer, G. F., Dressel, H., Puhan, M. A., Menges, D.
10.1101/2023.04.17.23288664 — Posted: 2023-04-19
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Staplin, N., Peto, L., Emberson, J. R., Campbell, M., Pessoa-Amorim, G., Basnyat, B., Thwaites, L., Van Doorn, R., Hamers, R. L., Nel, J., Amuasi, J., Rawal, M., Ghosh, D., Douse, J., Hamilton, F., Kerry, A., Thu-Ta, P., Widdrington, J., Green, C., Desai, P., Stewart, R., Phong, N. T., Baillie, J. K., Buch, M. H., Faust, S. N., Jaki, T., Jeffery, K., Juszczak, E., Knight, M., Lim, W. S., Montgomery, A., Mukherjee, A., Mumford, A., Rowan, K., Thwaites, G., Mafham, M., Haynes, R., Landray, M. J.
10.1101/2023.04.13.23288469 — Posted: 2023-04-19
Post-COVID-19 syndrome and insulin resistance 20 months after a mild COVID-19
FIERRO, P., MARTIN, D., PARIENTE-RODRIGO, E., GARCIA-GARRIDO, A., BASTERRECHEA, H., PETITTA, B., BIANCONI, C., HERRAN, S., BERRUETA, A., JORRIN, A., GOMEZ-PEREZ, A., CASADO, R., CUADRADO, A., RAMOS-BARRON, C., HERNANDEZ-HERNANDEZ, J. L.
10.1101/2023.04.17.23288637 — Posted: 2023-04-19
An ex vivo human precision-cut lung slice platform provides insight into SARS-CoV-2 pathogenesis and antiviral drug efficacy
Zhang, X., Pechous, R. D., Malaviarachchi, P. A., Banerjee, S. K., Byrum, S., Alkam, D., Ghaffarieh, A., Kurten, R. C., Kennedy, J. L.
10.1101/2023.04.18.537373 — Posted: 2023-04-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).